Senate passes approps
This article was originally published in The Gray Sheet
Executive Summary
Reconciled version of FY 2006 FDA appropriations bill (HR 2744) provides over $222.7 mil. to CDRH - "an increase of $7.8 mil. over the FY 2005 level" - and "fully funds FDA's device review program," AdvaMed says in a Nov. 4 release. The Senate agreed to the conference report Nov. 3 by an 81-18 vote. The House passed the same language Oct. 28 (1"The Gray Sheet" Oct. 31, 2005, In Brief)...